Malaysia
· Delayed Price · Currency is MYR Genetec Technology Berhad Statistics
Total Valuation
KLSE:GENETEC has a market cap or net worth of MYR 713.98 million. The enterprise value is 632.54 million.
| Market Cap | 713.98M |
| Enterprise Value | 632.54M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:GENETEC has 780.31 million shares outstanding. The number of shares has increased by 4.52% in one year.
| Current Share Class | 780.31M |
| Shares Outstanding | 780.31M |
| Shares Change (YoY) | +4.52% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 17.81% |
| Owned by Institutions (%) | 30.67% |
| Float | 597.14M |
Valuation Ratios
The trailing PE ratio is 10.30 and the forward PE ratio is 18.73.
| PE Ratio | 10.30 |
| Forward PE | 18.73 |
| PS Ratio | 2.57 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 44.94 |
| P/OCF Ratio | 21.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 39.81.
| EV / Earnings | 9.18 |
| EV / Sales | 2.28 |
| EV / EBITDA | 8.02 |
| EV / EBIT | 8.73 |
| EV / FCF | 39.81 |
Financial Position
The company has a current ratio of 6.80, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.80 |
| Quick Ratio | 6.46 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 1.43 |
| Interest Coverage | 29.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.37% |
| Revenue Per Employee | 726,708 |
| Profits Per Employee | 180,364 |
| Employee Count | 382 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KLSE:GENETEC has paid 4.67 million in taxes.
| Income Tax | 4.67M |
| Effective Tax Rate | 6.46% |
Stock Price Statistics
The stock price has decreased by -58.18% in the last 52 weeks. The beta is -0.17, so KLSE:GENETEC's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -58.18% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 42.10 |
| Average Volume (20 Days) | 6,874,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:GENETEC had revenue of MYR 277.60 million and earned 68.90 million in profits. Earnings per share was 0.09.
| Revenue | 277.60M |
| Gross Profit | 87.07M |
| Operating Income | 72.67M |
| Pretax Income | 72.31M |
| Net Income | 68.90M |
| EBITDA | 76.62M |
| EBIT | 72.67M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 164.40 million in cash and 22.71 million in debt, giving a net cash position of 141.70 million or 0.18 per share.
| Cash & Cash Equivalents | 164.40M |
| Total Debt | 22.71M |
| Net Cash | 141.70M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 496.73M |
| Book Value Per Share | 0.63 |
| Working Capital | 360.16M |
Cash Flow
In the last 12 months, operating cash flow was 33.80 million and capital expenditures -17.91 million, giving a free cash flow of 15.89 million.
| Operating Cash Flow | 33.80M |
| Capital Expenditures | -17.91M |
| Free Cash Flow | 15.89M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 31.36%, with operating and profit margins of 26.18% and 24.82%.
| Gross Margin | 31.36% |
| Operating Margin | 26.18% |
| Pretax Margin | 26.05% |
| Profit Margin | 24.82% |
| EBITDA Margin | 27.60% |
| EBIT Margin | 26.18% |
| FCF Margin | 5.72% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 2.19%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 2.19% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -4.52% |
| Shareholder Yield | -2.35% |
| Earnings Yield | 9.65% |
| FCF Yield | 2.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 7, 2022. It was a forward split with a ratio of 13.
| Last Split Date | Jan 7, 2022 |
| Split Type | Forward |
| Split Ratio | 13 |
Scores
KLSE:GENETEC has an Altman Z-Score of 16.85 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.85 |
| Piotroski F-Score | 4 |